5-fluorouracil pharmacogenomics: still rocking after all these years?
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-fluorouracil pharmacogenomics: still rocking after all these years?
Authors
Keywords
-
Journal
PHARMACOGENOMICS
Volume 12, Issue 2, Pages 251-265
Publisher
Future Medicine Ltd
Online
2011-02-19
DOI
10.2217/pgs.10.167
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlations of Clinicopathological Factors with Protein Expression Levels of Thymidylate Synthase, Dihydropyrimidine Dehydrogenase and Orotate Phosphoribosyltransferase in Colorectal Cancer
- (2010) Tetsuo Sumi et al. CHEMOTHERAPY
- Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity
- (2010) André B. P. van Kuilenburg et al. HUMAN GENETICS
- Clinical significance of dihydropyrimidine dehydrogenase and thymidylate synthase expression in patients with pancreatic cancer
- (2010) Osamu Nakahara et al. International Journal of Clinical Oncology
- Thymidylate synthase germline polymorphisms in rectal cancer patients treated with neoadjuvant chemoradiotherapy based on 5-fluorouracil
- (2010) David Páez et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Predictors of survival and toxicity in patients on adjuvant therapy with 5-fluorouracil for colorectal cancer
- (2009) M Gusella et al. BRITISH JOURNAL OF CANCER
- Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients
- (2009) Marie-Christine Etienne-Grimaldi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Predictive and prognostic markers for the outcome of chemotherapy in advanced colorectal cancer, a retrospective analysis of the phase III randomised CAIRO study
- (2009) Miriam Koopman et al. EUROPEAN JOURNAL OF CANCER
- C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation
- (2009) Elena De Mattia et al. EUROPEAN JOURNAL OF CANCER
- Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer
- (2009) Yue Hong CUI et al. Journal of Digestive Diseases
- MTHFRgene polymorphisms and response to chemotherapy in colorectal cancer: a meta-analysis
- (2009) Elias Zintzaras et al. PHARMACOGENOMICS
- Dihydropyrimidine dehydrogenase gene variation and severe 5-fluorouracil toxicity: a haplotype assessment
- (2009) Ursula Amstutz et al. PHARMACOGENOMICS
- Prognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy
- (2008) R. Soong et al. ANNALS OF ONCOLOGY
- Prediction of the effect of capecitabine in gastric cancer by immunohistochemical staining of thymidine phosphorylase and dihydropyrimidine dehydrogenase
- (2008) Wasaburo Koizumi et al. ANTI-CANCER DRUGS
- Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapy
- (2008) F Graziano et al. BRITISH JOURNAL OF CANCER
- Significance of dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expressions in hepatocellular carcinoma
- (2008) Akira Nii et al. HEPATOLOGY RESEARCH
- Thymidylate synthase genotyping is more predictive for therapy response than immunohistochemistry in patients with colon cancer
- (2008) Marleen J. Gosens et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes
- (2008) Bengt Gustavsson et al. INTERNATIONAL JOURNAL OF CANCER
- Hypermethylation of the DPYD promoter region is not a major predictor of severe toxicity in 5-fluorouracil based chemotherapy
- (2008) Ursula Amstutz et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy
- (2008) Juan J. Grau et al. JOURNAL OF SURGICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started